9.794.21% ( -0.43 )
Delay Midday Break: Nov 16, 11:30:00Valuation
Current ValuationThe current P/E ratio is 126.16, above the reasonable range, cheaper than 1.54% of the time in the past 3 years, and the industry ranks 147/222, the industry Median 22.14.
126.16xP/E
¥10.22Stock price
¥0.08Earnings per share
126.16xP/E
Stock price¥10.22Earnings per share¥0.08
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 70.50x
- Typical range
- 44.89x–109.75x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 22.14x
0326496128
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 22.14x
0x40x80x120x160x200x
| Name/Symbol | |||
|---|---|---|---|
688166SHBrightGene | 123.14x | -- | ¥12.59B |
688321SHChipscreen | 125.56x | -- | ¥8.96B |
300194SZFuan Pharmaceutical | 120.87x | -- | ¥4.20B |
603520SHStarry | 127.82x | 1,350.00% | ¥3.40B |
300534SZLongshenrongfa Pharmaceutical Industry | 126.16x | -- | ¥3.10B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
